Comparison Overview

Sanofi

VS

The Janssen Pharmaceutical Companies of Johnson & Johnson

Sanofi

46 Avenue de la Grande-Armée, Paris, France, 75017, FR
Last Update: 2025-12-09
View Profile
Between 800 and 849
http://www.sanofi.com

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 88,229
Subsidiaries: 6
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

The Janssen Pharmaceutical Companies of Johnson & Johnson

1000 U.S. Highway 202, Raritan, New Jersey, US
Last Update: 2025-12-09
Between 750 and 799
http://www.janssen.com

At Janssen, we never stop working toward a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep working tirelessly to make that future a reality for patients everywhere, by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Arterial Hypertension. Visit us: www.janssen.com Follow us: @JanssenGlobal on Twitter and Instagram Watch our videos on our YouTube channel: http://bit.ly/1LY2xQ5

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 14,253
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/sanofi.jpeg
Sanofi
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/janssen-pharmaceutical-companies-of-johnson-and-johnson.jpeg
The Janssen Pharmaceutical Companies of Johnson & Johnson
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Sanofi
100%
Compliance Rate
0/4 Standards Verified
The Janssen Pharmaceutical Companies of Johnson & Johnson
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Sanofi in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for The Janssen Pharmaceutical Companies of Johnson & Johnson in 2025.

Incident History — Sanofi (X = Date, Y = Severity)

Sanofi cyber incidents detection timeline including parent company and subsidiaries

Incident History — The Janssen Pharmaceutical Companies of Johnson & Johnson (X = Date, Y = Severity)

The Janssen Pharmaceutical Companies of Johnson & Johnson cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/sanofi.jpeg
Sanofi
Incidents

No Incident

https://images.rankiteo.com/companyimages/janssen-pharmaceutical-companies-of-johnson-and-johnson.jpeg
The Janssen Pharmaceutical Companies of Johnson & Johnson
Incidents

No Incident

FAQ

Sanofi company demonstrates a stronger AI Cybersecurity Score compared to The Janssen Pharmaceutical Companies of Johnson & Johnson company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, The Janssen Pharmaceutical Companies of Johnson & Johnson company has disclosed a higher number of cyber incidents compared to Sanofi company.

In the current year, The Janssen Pharmaceutical Companies of Johnson & Johnson company and Sanofi company have not reported any cyber incidents.

Neither The Janssen Pharmaceutical Companies of Johnson & Johnson company nor Sanofi company has reported experiencing a ransomware attack publicly.

Neither The Janssen Pharmaceutical Companies of Johnson & Johnson company nor Sanofi company has reported experiencing a data breach publicly.

Neither The Janssen Pharmaceutical Companies of Johnson & Johnson company nor Sanofi company has reported experiencing targeted cyberattacks publicly.

Neither Sanofi company nor The Janssen Pharmaceutical Companies of Johnson & Johnson company has reported experiencing or disclosing vulnerabilities publicly.

Neither Sanofi nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds any compliance certifications.

Neither company holds any compliance certifications.

Sanofi company has more subsidiaries worldwide compared to The Janssen Pharmaceutical Companies of Johnson & Johnson company.

Sanofi company employs more people globally than The Janssen Pharmaceutical Companies of Johnson & Johnson company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Sanofi nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds SOC 2 Type 1 certification.

Neither Sanofi nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds SOC 2 Type 2 certification.

Neither Sanofi nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds ISO 27001 certification.

Neither Sanofi nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds PCI DSS certification.

Neither Sanofi nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds HIPAA certification.

Neither Sanofi nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, there is no handler for JSON parsing errors; SyntaxError from express.json() includes user input in the error message, which gets reflected in responses. User input (including HTML/JavaScript) can be exposed in error responses, creating an XSS risk if Content-Type isn't strictly enforced. This issue does not have a fix at the time of publication.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, when creating prompts, JSON requests are sent to define and modify the prompts via PATCH endpoint for prompt groups (/api/prompts/groups/:groupId). However, the request bodies are not sufficiently validated for proper input, enabling users to modify prompts in a way that was not intended as part of the front end system. The patchPromptGroup function passes req.body directly to updatePromptGroup() without filtering sensitive fields. This issue is fixed in version 0.8.1.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, when a user posts a question, the iconURL parameter of the POST request can be modified by an attacker. The malicious code is then stored in the chat which can then be shared to other users. When sharing chats with a potentially malicious “tracker”, resources loaded can lead to loss of privacy for users who view the chat link that is sent to them. This issue is fixed in version 0.8.1.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss4
Base: 8.6
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

MaxKB is an open-source AI assistant for enterprise. Versions 2.3.1 and below have improper file permissions which allow attackers to overwrite the built-in dynamic linker and other critical files, potentially resulting in privilege escalation. This issue is fixed in version 2.4.0.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
References
Description

MaxKB is an open-source AI assistant for enterprise. In versions 2.3.1 and below, the tool module allows an attacker to escape the sandbox environment and escalate privileges under certain concurrent conditions. This issue is fixed in version 2.4.0.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
References